StonvexLoading…
StonvexStonvexStonvexCore line items from BGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.83B | $1.93B | $2.06B | $2.16B |
Operating Income | $97.15M | $-177.28M | $80.42M | $98.63M |
Net Income | $-43.26M | $-251.25M | $-66.20M | $-11.37M |
EPS (Diluted) | $-0.54 | $-3.18 | $-0.89 | $-0.16 |
Total Assets | $2.83B | $2.99B | $3.46B | $3.84B |
Total Liabilities | $2.38B | $2.47B | $2.63B | $2.97B |
Cash & Equivalents | $56.29M | $50.58M | $41.09M | $45.44M |
Free Cash Flow OCF − CapEx | $70.75M | $103.65M | $222.07M | $-16.32M |
Shares Outstanding | 79.98M | 79.14M | 78.62M | 71.67M |